People who should not take semaglutide include those with medullary thyroid cancer history, MEN2, a prior severe allergic reaction, or pregnancy.
People who should not take semaglutide include anyone with a personal or family history of medullary thyroid cancer (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2), anyone who has had a severe allergic reaction to the drug, and women who are pregnant or breastfeeding. People with type 1 diabetes, a history of pancreatitis, gastroparesis, or severe kidney or liver disease should also talk with a prescriber before starting semaglutide.
Semaglutide is a GLP-1 receptor agonist sold as Ozempic, Wegovy, and Rybelsus. It is FDA-approved for type 2 diabetes and for chronic weight management in eligible adults, and it works partly by slowing stomach emptying and changing appetite signaling. That mechanism is exactly why certain medical histories matter.
Absolute reasons to avoid semaglutide
Prescribing information lists a small number of situations where semaglutide should not be used at all. These are not personal preferences or gray areas — they are safety rules based on how the drug affects the body.
- Personal or family history of medullary thyroid cancer. GLP-1 drugs caused thyroid C-cell tumors in rodents, and that risk cannot be ruled out in humans. A family history of MTC is a standard reason to be excluded.
- MEN2 (multiple endocrine neoplasia syndrome type 2). People with this inherited syndrome have a higher baseline risk of medullary thyroid cancer, so semaglutide is not considered appropriate for them.
- A previous severe allergic reaction to semaglutide or an ingredient in the product. Symptoms can include hives, swelling of the face or throat, and trouble breathing.
- Pregnancy and breastfeeding. Wegovy is contraindicated during pregnancy and Ozempic is not recommended. Weight loss is not a goal during pregnancy, and the effects on a developing fetus are not well established.
Semaglutide is also not approved for type 1 diabetes. It does not replace insulin, and using it instead of insulin can be dangerous.
Conditions that call for extra caution
Some people are not automatically excluded, but they need a closer look before starting semaglutide. A prescriber will weigh the benefits against the risks and may recommend monitoring, a lower starting dose, or a different treatment.
| Condition or situation | Typical guidance | Why it matters |
|---|---|---|
| History of pancreatitis | Usually avoided or used only with clear justification | GLP-1 drugs have been linked to pancreatitis in some reports |
| Severe kidney disease or dialysis | Use with caution and close monitoring | Dehydration from vomiting or diarrhea can worsen kidney function |
| Diabetic retinopathy | Eye exam before and during treatment | Rapid blood sugar improvement can temporarily worsen retinopathy |
| Gastroparesis or severe GERD | Often avoided | Semaglutide slows stomach emptying even further |
| History of an eating disorder | Careful screening before prescribing | Appetite suppression can interact with disordered eating patterns |
| Age over 75 or frailty | Start low and monitor closely | Higher risk of dehydration and muscle loss |
Medications to review before starting
Many patients ask what can you not take with semaglutide, and the honest answer is that very few drugs are absolutely forbidden. The bigger issue is how semaglutide interacts with other treatments.
- Insulin and sulfonylureas. Combining them with semaglutide raises the risk of low blood sugar, so doses often need to be reduced.
- Other GLP-1 drugs. Stacking semaglutide with another GLP-1 receptor agonist is not recommended.
- Oral medications. Rybelsus, the oral form, can change how quickly other pills are absorbed, so some drugs need to be taken at different times.
- Medications that affect stomach emptying. Combining them may worsen nausea, vomiting, or constipation.
Always give your prescriber a full medication list, including supplements and anything bought without a prescription.
Warning signs to stop and call a doctor
Some side effects are common and manageable, while others need immediate attention. Seek medical care if you experience any of the following:
- Severe or persistent abdominal pain that may radiate to your back, which can signal pancreatitis
- Persistent vomiting or diarrhea that prevents you from keeping fluids down
- Signs of dehydration such as dizziness, dark urine, or confusion
- Vision changes, especially if you have diabetes
- Swelling of the lips, tongue, or throat, or difficulty breathing
- A new lump or swelling in the neck
Do not restart semaglutide on your own after a serious reaction. Contact your prescriber first.
Other peptides raise the same screening questions
Semaglutide is not the only injectable people research before starting. Anyone asking who should not take sermorelin, or typing who should not take pt 141 into a search bar, is really asking the same question: does my health history disqualify me? The answer always depends on the specific compound, the dose, and the person.
Peptide and hormone products sold online are frequently unregulated, and many are not FDA-approved for human use. That makes a prescriber's review even more important than it is for a pharmacy-dispensed GLP-1 drug.
How to decide with your prescriber
Bring a written list of your diagnoses, family history, current medications, and prior surgeries to your appointment. Ask directly whether your thyroid history, kidney function, or digestive condition changes the risk-benefit picture for you.
Blood work usually includes kidney and liver function, blood sugar markers, and sometimes thyroid labs. If you have diabetes, your eye exam should be up to date before you start.
Semaglutide is not appropriate for everyone, and that is not a personal failure. It simply means a different option may fit your health history better, and a licensed healthcare professional is the right person to make that call.
Frequently Asked Questions
Who should not take semaglutide?
Semaglutide is not appropriate for people with a personal or family history of medullary thyroid cancer or MEN2, anyone who has had a severe allergic reaction to it, and women who are pregnant or breastfeeding. People with type 1 diabetes, a history of pancreatitis, gastroparesis, or severe kidney disease should speak with a prescriber first. Semaglutide is not FDA-approved for type 1 diabetes.
Can you take semaglutide if you have thyroid problems?
Most common thyroid conditions, such as hypothyroidism or Hashimoto's disease, are not automatic disqualifiers. The specific concern is medullary thyroid cancer and the inherited syndrome MEN2, which are listed as contraindications. Tell your prescriber about any thyroid history, including nodules or prior thyroid cancer, before starting.
Can you take semaglutide while pregnant or breastfeeding?
No. Wegovy is contraindicated during pregnancy and Ozempic is not recommended, and semaglutide is not advised while breastfeeding. Women who could become pregnant are usually encouraged to use contraception while taking it. Contact your prescriber right away if you become pregnant while using semaglutide.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.